MeiraGTx Holdings (MGTX) Total Liabilities (2017 - 2025)
MeiraGTx Holdings (MGTX) reported Total Liabilities of $250.2 million for Q4 2025, up 23.92% on a YoY basis from $201.9 million in Q4 2024, and up 8.78% quarter-over-quarter from $230.0 million in Q3 2025.
MeiraGTx Holdings (MGTX) Total Liabilities (2017 - 2025) Analysis & Trends
MeiraGTx Holdings has reported Total Liabilities for 9 years, with the latest figure at $250.2 million in Q4 2025.
- For the quarter ending Q4 2025, Total Liabilities rose 23.92% year-over-year to $250.2 million; the trailing twelve-month figure through Dec 2025 stood at $250.2 million (up 23.92% YoY), and the FY2025 full-year result was $250.2 million, up 23.92% from the prior year.
- Total Liabilities for Q4 2025 stood at $250.2 million, up from $230.0 million in the prior quarter.
- The five-year high for Total Liabilities was $250.2 million in Q4 2025, with the low at $110.5 million in Q2 2022.
- Historically, Total Liabilities has averaged $175.1 million across 5 years, with a median of $187.1 million in 2023.
- Annual changes were most pronounced in 2022 — Total Liabilities decreased 8.72% — and 2023, when it soared 69.01%.
- MeiraGTx Holdings' Total Liabilities stood at $134.8 million in 2021, then jumped by 48.78% to $200.5 million in 2022, then dropped by 5.95% to $188.6 million in 2023, then rose by 7.08% to $201.9 million in 2024, then advanced by 23.92% to $250.2 million in 2025.
- The last three Total Liabilities figures came in at $250.2 million (Q4 2025), $230.0 million (Q3 2025), and $195.8 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.74 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 15.48 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 731.60 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 10.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 19.51 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 943,068.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 7.12 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 137.56 Mn |
| 10 | MeiraGTx Holdings | 910.47 Mn | 844.54 Mn | 74.89 Mn | 250.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 250.22 Mn |
| Sep 30, 2025 | 230.03 Mn |
| Jun 30, 2025 | 195.76 Mn |
| Mar 31, 2025 | 190.92 Mn |
| Dec 31, 2024 | 201.92 Mn |
| Sep 30, 2024 | 203.75 Mn |
| Jun 30, 2024 | 186.61 Mn |
| Mar 31, 2024 | 187.50 Mn |
| Dec 31, 2023 | 188.57 Mn |
| Sep 30, 2023 | 175.31 Mn |
| Jun 30, 2023 | 186.74 Mn |
| Mar 31, 2023 | 197.92 Mn |
| Dec 31, 2022 | 200.50 Mn |
| Sep 30, 2022 | 178.74 Mn |
| Jun 30, 2022 | 110.49 Mn |
| Mar 31, 2022 | 126.41 Mn |
| Dec 31, 2021 | 134.76 Mn |
| Sep 30, 2021 | 115.50 Mn |
| Jun 30, 2021 | 121.05 Mn |
| Mar 31, 2021 | 118.88 Mn |